BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect 2022;28:202-21. [PMID: 34715347 DOI: 10.1016/j.cmi.2021.10.005] [Cited by in Crossref: 231] [Cited by in F6Publishing: 221] [Article Influence: 231.0] [Reference Citation Analysis]
Number Citing Articles
1 Sanhueza ME, San Martín P, Brantes L, Caro S, Carrasco G, Machuca E. Efficacy of vaccination against the SARS-CoV-2 virus in patients with chronic kidney disease on hemodialysis. Hum Vaccin Immunother 2023;19:2173904. [PMID: 36785953 DOI: 10.1080/21645515.2023.2173904] [Reference Citation Analysis]
2 Clingan SE, Cousins SJ, Lin C, Nguyen TE, Hser YI, Mooney LJ. Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder. Ann Med 2023;55:480-9. [PMID: 36692029 DOI: 10.1080/07853890.2023.2169342] [Reference Citation Analysis]
3 Hernández-Díazcouder A, Díaz-Godínez C, Carrero JC. Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update. Appl Microbiol Biotechnol 2023;107:2131-41. [PMID: 36917275 DOI: 10.1007/s00253-023-12468-6] [Reference Citation Analysis]
4 Fu Z, Liang D, Zhang W, Shi D, Ma Y, Wei D, Xi J, Yang S, Xu X, Tian D, Zhu Z, Guo M, Jiang L, Yu S, Wang S, Jiang F, Ling Y, Wang S, Chen S, Liu F, Tan Y, Fan X. Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak in Shanghai. Front Med 2023. [PMID: 36949347 DOI: 10.1007/s11684-022-0977-3] [Reference Citation Analysis]
5 Sun J, Ma X, Zhang M, Xie M, Zhang X, Han X, Li X, Zhou E, Wang J, Wang J. Comparisons of lymphocytes profiles and inflammatory cytokines levels in blood of patients with differed severity of infection by human adenovirus type 7. BMC Infect Dis 2023;23:174. [PMID: 36949406 DOI: 10.1186/s12879-023-08132-z] [Reference Citation Analysis]
6 Zornikova KV, Sheetikov SA, Rusinov AY, Iskhakov RN, Bogolyubova AV. Architecture of the SARS-CoV-2-specific T cell repertoire. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1070077] [Reference Citation Analysis]
7 Li H, Ma Q, Ren J, Guo W, Feng K, Li Z, Huang T, Cai Y. Immune responses of different COVID-19 vaccination strategies by analyzing single-cell RNA sequencing data from multiple tissues using machine learning methods. Front Genet 2023;14. [DOI: 10.3389/fgene.2023.1157305] [Reference Citation Analysis]
8 Intarapanya T, Suratanee A, Pattaradilokrat S, Plaimas K. Modeling the Spread of COVID-19 with the Control of Mixed Vaccine Types during the Pandemic in Thailand. TropicalMed 2023;8:175. [DOI: 10.3390/tropicalmed8030175] [Reference Citation Analysis]
9 Ott O, Herrmann E, Schulz A, Lindhoff-last E. The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination. IJMS 2023;24:5644. [DOI: 10.3390/ijms24065644] [Reference Citation Analysis]
10 Stoliaroff-Pepin A, Peine C, Herath T, Lachmann J, Hellenbrand W, Perriat D, Dörre A, Nitsche A, Michel J, Grossegesse M, Hofmann N, Rinner T, Kohl C, Brinkmann A, Meyer T, Stern D, Treindl F, Dorner BG, Hein S, Werel L, Hildt E, Gläser S, Schühlen H, Isner C, Peric A, Ghouzi A, Reichardt A, Janneck M, Lock G, Huster D, Grünewald T, Schaade L, Wichmann O, Harder T. Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study. Infection 2023;:1-10. [PMID: 36913112 DOI: 10.1007/s15010-023-02012-z] [Reference Citation Analysis]
11 Achiron A, Mandel M, Dreyer-Alster S, Magalashvili D, Menascu S, Warszawer Y, Dolev M, Didikin M, Harari G, Sonis P, Falb R, Gurevich M. In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab. Mult Scler Relat Disord 2023;72:104616. [PMID: 36933299 DOI: 10.1016/j.msard.2023.104616] [Reference Citation Analysis]
12 Al-Kassab-Córdova A, Silva-Perez C, Mendez-Guerra C, Herrera-Añazco P, Benites-Zapata VA. Factors associated with not receiving the primary series and booster dose of the COVID-19 vaccine among Venezuelan migrants in Peru: A population-based cross-sectional study. Travel Med Infect Dis 2023;53:102563. [PMID: 36898490 DOI: 10.1016/j.tmaid.2023.102563] [Reference Citation Analysis]
13 Akbar SMF, Al Mahtab M, Khan S. Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines. Vaccines 2023;11:615. [DOI: 10.3390/vaccines11030615] [Reference Citation Analysis]
14 Tapia D, Reyes-Sandoval A, Sanchez-Villamil JI. Protein-based Nanoparticle Vaccine Approaches Against Infectious Diseases. Arch Med Res 2023:S0188-4409(23)00016-4. [PMID: 36894463 DOI: 10.1016/j.arcmed.2023.02.003] [Reference Citation Analysis]
15 German-cortés J, Vilar-hernández M, Rafael D, Abasolo I, Andrade F. Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment. Pharmaceutics 2023;15:831. [DOI: 10.3390/pharmaceutics15030831] [Reference Citation Analysis]
16 Joachim Wen Kien Yau, Martin Yong Kwong Lee, Eda Qiao Yan Lim, Janice Yu Jin Tan, Kelvin Bryan Jek Chen Tan, Raymond Swee Boon Chua. Genesis, evolution and effectiveness of Singapore's national sorting logic and home recovery policies in handling the COVID-19 Delta and Omicron waves. Lancet Reg Health West Pac 2023:100719. [ DOI: 10.1016/j.lanwpc.2023.100719] [Reference Citation Analysis]
17 Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, Soliman Mohammadi-Samani. Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2. Int Immunopharmacol 2023:109968. [ DOI: 10.1016/j.intimp.2023.109968] [Reference Citation Analysis]
18 Basile A, Zannella C, De Marco M, Sanna G, Franci G, Galdiero M, Manzin A, De Laurenzi V, Chetta M, Rosati A, Turco MC, Marzullo L. Spike-mediated viral membrane fusion is inhibited by a specific anti-IFITM2 monoclonal antibody. Antiviral Res 2023;211:105546. [PMID: 36669656 DOI: 10.1016/j.antiviral.2023.105546] [Reference Citation Analysis]
19 Moghadam Fard T, Shokri M, Mirfazeli FS, Mohammadsadeghi H, Shafiei N, Salehian R, Riahi T. COVID-19 vaccination hesitancy is not all a conspiracy theory: A qualitative study from Iran. Acta Psychol (Amst) 2023;233:103839. [PMID: 36652822 DOI: 10.1016/j.actpsy.2023.103839] [Reference Citation Analysis]
20 Sauré D, O'Ryan M, Torres JP, Zuñiga M, Soto-Rifo R, Valiente-Echeverría F, Gaete-Argel A, Neira I, Saavedra V, Acevedo ML, Archila C, Acuña F, Rain M, Basso LJ. COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study. Lancet Microbe 2023;4:e149-58. [PMID: 36716754 DOI: 10.1016/S2666-5247(22)00290-7] [Reference Citation Analysis]
21 Valdebenito-navarrete H, Fuentes-barrera V, Smith CT, Salas-burgos A, Zuniga FA, Gomez LA, García-cancino A. Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2? Biology 2023;12:384. [DOI: 10.3390/biology12030384] [Reference Citation Analysis]
22 Oh DQP, Grothe I, Lukaß H, Kreiter AK, Hoffmann M, Wegener D. Monitoring and immunogenicity of SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta). Sci Rep 2023;13:3274. [PMID: 36841887 DOI: 10.1038/s41598-023-30473-7] [Reference Citation Analysis]
23 Saeedullah U, Abbas AM, Ward C, Bayya M, Bhandari J, Abbas AM, Deleon J, Reiss AB. A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously. Vaccines 2023;11:541. [DOI: 10.3390/vaccines11030541] [Reference Citation Analysis]
24 Pavan M, Moro S. Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics. Int J Mol Sci 2023;24. [PMID: 36901832 DOI: 10.3390/ijms24054401] [Reference Citation Analysis]
25 Milne C, Wagner R, Cano F, Bruysters M, Waeterloos G, Pullirsch D, Wierer M, Mallet L. Independent control of COVID-19 vaccines by EU Official Control Authority Batch Release: challenges, strengths and successes. NPJ Vaccines 2023;8:22. [PMID: 36823287 DOI: 10.1038/s41541-023-00617-x] [Reference Citation Analysis]
26 Peeters G, Van Remoortel A, Nagels G, Van Schependom J, D'haeseleer M. Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm 2023;10. [PMID: 36807080 DOI: 10.1212/NXI.0000000000200089] [Reference Citation Analysis]
27 Toutoudaki K, Dimakakou M, Androutsakos T. Efficacy, Safety and Immunogenicity of Anti-SARS-CoV-2 Vaccines in Patients with Cirrhosis: A Narrative Review. Vaccines (Basel) 2023;11. [PMID: 36851329 DOI: 10.3390/vaccines11020452] [Reference Citation Analysis]
28 Maghsood F, Ghorbani A, Yadegari H, Golsaz-Shirazi F, Amiri MM, Shokri F. SARS-CoV-2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design. Rev Med Virol 2023;:e2431. [PMID: 36790816 DOI: 10.1002/rmv.2431] [Reference Citation Analysis]
29 Bao P, Gong J, Mu M, Que Y, Hu P, Luo J, Chang C, Xu G. Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity. Chin Med J (Engl) 2023. [PMID: 36806245 DOI: 10.1097/CM9.0000000000002270] [Reference Citation Analysis]
30 Saadedine M, El Sabeh M, Borahay MA, Daoud G. The influence of COVID-19 infection-associated immune response on the female reproductive system†. Biol Reprod 2023;108:172-82. [PMID: 36173920 DOI: 10.1093/biolre/ioac187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Wang H, Yu B, Chen X, Yan H. Global pattern and determinants of coronavirus disease 2019 (COVID-19) vaccine coverage and progression: a global ecological study. Glob Health J 2023. [PMID: 36785805 DOI: 10.1016/j.glohj.2023.02.003] [Reference Citation Analysis]
32 Xu M, Bi J, Liang B, Wang X, Mo R, Feng N, Yan F, Wang T, Yang S, Zhao Y, Xia X. PEGylation Prolongs the Half-Life of Equine Anti-SARS-CoV-2 Specific F(ab')(2). Int J Mol Sci 2023;24. [PMID: 36834803 DOI: 10.3390/ijms24043387] [Reference Citation Analysis]
33 Miao G, Chen Z, Cao H, Wu W, Chu X, Liu H, Zhang L, Zhu H, Cai H, Lu X, Shi J, Liu Y, Feng T. From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era. Biomed Pharmacother 2023;158:114208. [PMID: 36800265 DOI: 10.1016/j.biopha.2022.114208] [Reference Citation Analysis]
34 Lim SP. Targeting SARS-CoV-2 and host cell receptor interactions. Antiviral Res 2023;210:105514. [PMID: 36581047 DOI: 10.1016/j.antiviral.2022.105514] [Reference Citation Analysis]
35 Zhang Y, Lv Q, Qi F, Li F, Deng R, Liang X, Liu M, Yan Y, Bao L. Comparison of the replication and neutralization of different SARS-CoV-2 Omicron subvariants in vitro. Animal Model Exp Med 2023;6:51-6. [PMID: 36808904 DOI: 10.1002/ame2.12302] [Reference Citation Analysis]
36 Barrière J, Frank F, Besançon L, Samuel A, Saada V, Billy E, Al-Ahmad A, Seitz-Polski B, Robert J. Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers. Stem Cell Rev Rep 2023;19:568-72. [PMID: 36287337 DOI: 10.1007/s12015-022-10465-2] [Reference Citation Analysis]
37 Plested JS, Zhu M, Cloney-Clark S, Massuda E, Patel U, Klindworth A, Massare MJ, Cai R, Fries L, Glenn G, Kalkeri R. Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation. Microorganisms 2023;11. [PMID: 36838333 DOI: 10.3390/microorganisms11020368] [Reference Citation Analysis]
38 Zappella N, Montravers P. Commentary on "Lung Transplantation for COVID-19 Pulmonary Sequelae": Beautiful Story, Already History? Transplantation 2023;107:305-6. [PMID: 36476617 DOI: 10.1097/TP.0000000000004415] [Reference Citation Analysis]
39 Chiu W, Schepers J, Francken T, Vangeel L, Abbasi K, Jochmans D, De Jonghe S, Thibaut HJ, Thiel V, Neyts J, Laporte M, Leyssen P. Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery. Antiviral Res 2023;210:105506. [PMID: 36565756 DOI: 10.1016/j.antiviral.2022.105506] [Reference Citation Analysis]
40 Chow MYT, Pan HW, Seow HC, Lam JKW. Inhalable neutralizing antibodies - promising approach to combating respiratory viral infections. Trends Pharmacol Sci 2023;44:85-97. [PMID: 36566131 DOI: 10.1016/j.tips.2022.11.006] [Reference Citation Analysis]
41 Keske Ş, Güney-Esken G, Vatansever C, Beşli Y, Kuloğlu ZE, Nergiz Z, Barlas T, Şencanlı Ö, Kuşkucu MA, Palaoğlu E, Can F, Önder Ergönül. Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms. Clin Microbiol Infect 2023;29:221-4. [PMID: 35853589 DOI: 10.1016/j.cmi.2022.07.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Nonaka M, Neshige S, Yamada H, Ishibashi H, Takebayashi Y, Nakamori M, Aoki S, Yamazaki Y, Shishido T, Agari D, Ochi K, Iida K, Maruyama H. Immediate and 6-month seizure outcomes following first and second SARS-CoV2 mRNA vaccinations: A multicenter study with a nationwide survey. Epilepsy Behav 2023;139:109070. [PMID: 36701937 DOI: 10.1016/j.yebeh.2022.109070] [Reference Citation Analysis]
43 Roth N, Gergen J, Kovacikova K, Mueller SO, Ulrich L, Schön J, Halwe NJ, Fricke C, Corleis B, Dorhoi A, Hoffmann D, Beer M, Maione D, Petsch B, Rauch S. Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models. Vaccines (Basel) 2023;11. [PMID: 36851196 DOI: 10.3390/vaccines11020318] [Reference Citation Analysis]
44 Al Kaabi N, Yang Y, Eldin Hussein S, Yang T, Abdalla J, Wang H, Lou Z, Chinese Center For Disease Control And Prevention, Bakkour A, Arafat A, China National Biotec Group Company Limited, Jiang Z, Tian Y, National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltd, Beijing Institute Of Biological Products Company Limited, Xiao P, Zaher W, Eltantawy I, Wang C, Xu G, Zhang Y, Yang X. Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi. Vaccines (Basel) 2023;11. [PMID: 36851177 DOI: 10.3390/vaccines11020299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Alhandod TA, Rabbani SI, Almuqbil M, Alshehri S, Hussain SA, Alomar NF, Mir MA, Asdaq SMB. A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia. Vaccines (Basel) 2023;11. [PMID: 36851158 DOI: 10.3390/vaccines11020281] [Reference Citation Analysis]
46 Mouliou DS. The Deceptive COVID-19: Lessons from Common Molecular Diagnostics and a Novel Plan for the Prevention of the Next Pandemic. Diseases 2023;11. [PMID: 36810534 DOI: 10.3390/diseases11010020] [Reference Citation Analysis]
47 Borborema TS, Lima JS, Brito JCM, Siqueira-Batista R, Murao M. Thrombotic thrombocytopenic purpura and mushroom-shaped red blood cells secondary to COVID-19: A case report. Hematol Transfus Cell Ther 2023. [PMID: 36710912 DOI: 10.1016/j.htct.2023.01.001] [Reference Citation Analysis]
48 Xie Z, Hamadi HY, Mainous AG, Hong YR. Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity. Vaccine 2023;41:875-8. [PMID: 36567142 DOI: 10.1016/j.vaccine.2022.12.043] [Reference Citation Analysis]
49 Krause W. mRNA-From COVID-19 Treatment to Cancer Immunotherapy. Biomedicines 2023;11. [PMID: 36830845 DOI: 10.3390/biomedicines11020308] [Reference Citation Analysis]
50 Ferrara P, Ponticelli D, Losa L, Romeo C, Magliuolo R, Vitale A, Zampella A, Alleanza L, Borrelli M, Schiavone B, Mantovani LG. Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study. Vaccines (Basel) 2023;11. [PMID: 36851125 DOI: 10.3390/vaccines11020247] [Reference Citation Analysis]
51 Maple PAC. COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections. Vaccines (Basel) 2023;11. [PMID: 36851110 DOI: 10.3390/vaccines11020232] [Reference Citation Analysis]
52 Jiang X, Zhou J, Yu Z, Gu X, Lu Y, Ruan Y, Wang T. Exploration of Fuzheng Yugan Mixture on COVID-19 based on network pharmacology and molecular docking. Medicine (Baltimore) 2023;102:e32693. [PMID: 36701702 DOI: 10.1097/MD.0000000000032693] [Reference Citation Analysis]
53 Cosgun Y, Emanet N, Kamiloglu AÖ, Grage-Griebenow E, Hohensee S, Saschenbrecker S, Steinhagen K, Korukluoglu G. Humoral Immune Response to CoronaVac in Turkish Adults. Vaccines (Basel) 2023;11. [PMID: 36851093 DOI: 10.3390/vaccines11020216] [Reference Citation Analysis]
54 Geçer E, Yıldırım M, Akgül Ö, Sögütlü L, Akif Sezerol M, Tașçı Y. Satisfaction With Life Among Vaccinated Turkish People. European Journal of Psychology Open 2023. [DOI: 10.1024/2673-8627/a000028] [Reference Citation Analysis]
55 Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, He X, Liu M, Li PF, Yu T. CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther 2023;8:36. [PMID: 36646687 DOI: 10.1038/s41392-023-01309-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Wang C, Chen X, Zhao X, Huang X, Pan L. Value of internet of things-based diagnosis-treatment model in improving the quality of medical services during COVID-19 outbreak. Am J Transl Res 2023;15:573-81. [PMID: 36777865] [Reference Citation Analysis]
57 Ghoneum M, Abdulmalek S, Fadel HH. Biobran/MGN-3, an Arabinoxylan Rice Bran, Protects against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An In Vitro and In Silico Study. Nutrients 2023;15. [PMID: 36678324 DOI: 10.3390/nu15020453] [Reference Citation Analysis]
58 Sebastião CS, Sacomboio E, Francisco NM, Cassinela EK, Mateus A, David Z, Paixão J, de Vasconcelos JN, Morais J. Immune profile of healthcare professionals six months after vaccination or exposure to SARS-CoV-2 in Angola. Health Sci Rep 2023;6:e1058. [PMID: 36644315 DOI: 10.1002/hsr2.1058] [Reference Citation Analysis]
59 Łysek-Gładysińska M, Starz M, Borowiec-Sęk A, Sufin I, Wieczorek A, Chrapek M, Zarębska-Michaluk D, Sufin P, Głuszek S, Adamus-Białek W. The Levels of Anti-SARS-CoV-2 Spike Protein IgG Antibodies Before and After the Third Dose of Vaccination Against COVID-19. J Inflamm Res 2023;16:145-60. [PMID: 36660373 DOI: 10.2147/JIR.S394760] [Reference Citation Analysis]
60 Collatuzzo G, De Palma G, Violante FS, Porru S, Larese Filon F, Fabianova E, Violán C, Vimercati L, Leustean M, Rodriguez-Suarez MM, Sansone E, Sala E, Zunarelli C, Lodi V, Monaco MGL, Spiteri G, Negro C, Beresova J, Carrasco-Ribelles LA, Tafuri S, Asafo SS, Ditano G, Abedini M, Boffetta P. Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: An individual-level analysis within 13 months in the ORCHESTRA cohort. Front Immunol 2022;13:1079884. [PMID: 36713452 DOI: 10.3389/fimmu.2022.1079884] [Reference Citation Analysis]
61 Rivera-Torres J, Girón N, San José E. COVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older Adults. J Clin Med 2023;12. [PMID: 36675416 DOI: 10.3390/jcm12020488] [Reference Citation Analysis]
62 Ghosh A, Lalsare A, Chirmule N, Khare N, Kalakuntla P, Zarkar R, Pawar S, Sheth S. Teaching vaccine development in schools: Learnings from a survey and curriculum design for a course. Front Educ 2023;7. [DOI: 10.3389/feduc.2022.935683] [Reference Citation Analysis]
63 Wu C, He C, Yan J, Zhang H, Li L, Tian C, Chen N, Wang Q, Zhang Y, Lang H. Psychological Capital and Alienation among patients with COVID-19 infection: The mediating role of Social Support.. [DOI: 10.21203/rs.3.rs-2423920/v1] [Reference Citation Analysis]
64 Moreno J, Carvelli J, Lesaux A, Boucekine M, Tonon D, Bichon A, Gainnier M, Bourenne J. Ventilator Acquired Pneumonia in COVID-19 ICU Patients: A Retrospective Cohort Study during Pandemia in France. J Clin Med 2023;12. [PMID: 36675351 DOI: 10.3390/jcm12020421] [Reference Citation Analysis]
65 Ding J, Chen J, Yin X, Zhou J. Current understanding on long non-coding RNAs in immune response to COVID-19. Virus Res 2022;323:198956. [PMID: 36208691 DOI: 10.1016/j.virusres.2022.198956] [Reference Citation Analysis]
66 Yang H, Xie Y, Li C. Understanding the mechanisms for COVID-19 vaccine's protection against infection and severe disease. Expert Rev Vaccines 2023;22:186-92. [PMID: 36715150 DOI: 10.1080/14760584.2023.2174529] [Reference Citation Analysis]
67 Kanokudom S, Chansaenroj J, Suntronwong N, Assawakosri S, Yorsaeng R, Nilyanimit P, Aeemjinda R, Khanarat N, Vichaiwattana P, Klinfueng S, Thongmee T, Katanyutanon A, Thanasopon W, Arayapong J, Withaksabut W, Srimuan D, Thatsanatorn T, Sudhinaraset N, Wanlapakorn N, Honsawek S, Poovorawan Y. Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax(TM)) after homologous and heterologous two-dose regimens. Int J Infect Dis 2023;126:64-72. [PMID: 36427701 DOI: 10.1016/j.ijid.2022.11.022] [Reference Citation Analysis]
68 Gao W, Li Z, Guan Q, Cui W, Zheng B, Ding Q, Lv G, Xu J, Zhang W. Characterization and analysis of linear epitopes corresponding to SARS-CoV-2 outbreak in Jilin Province, China. J Med Virol 2023;95:e28323. [PMID: 36401153 DOI: 10.1002/jmv.28323] [Reference Citation Analysis]
69 Meo AS, Masood A, Shabbir U, Ali H, Nadeem Z, Meo SA, Alshahrani AN, AlAnazi S, Al-Masri AA, Al-Khlaiwi T. Adverse Effects of Sinopharm COVID-19 Vaccine among Vaccinated Medical Students and Health Care Workers. Vaccines (Basel) 2023;11. [PMID: 36679950 DOI: 10.3390/vaccines11010105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Czarnowska A, Kapica-Topczewska K, Tarasów E, Tarasiuk J, Chorąży M, Kochanowicz J, Kułakowska A. Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination. Front Neurol 2023;14:1097799. [PMID: 36873437 DOI: 10.3389/fneur.2023.1097799] [Reference Citation Analysis]
71 Sanz-Muñoz I, López-Mongil R, Sánchez-Martínez J, Sánchez-de Prada L, González MD, Pérez-SanJose D, Rojo-Rello S, Hernán-García C, Fernández-Espinilla V, de Lejarazu-Leonardo RO, Castrodeza-Sanz J, Eiros JM. Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people. Front Immunol 2023;14:1128302. [PMID: 36911673 DOI: 10.3389/fimmu.2023.1128302] [Reference Citation Analysis]
72 Li J, Huang F, Ma Q, Guo W, Feng K, Huang T, Cai YD. Identification of genes related to immune enhancement caused by heterologous ChAdOx1-BNT162b2 vaccines in lymphocytes at single-cell resolution with machine learning methods. Front Immunol 2023;14:1131051. [PMID: 36936955 DOI: 10.3389/fimmu.2023.1131051] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Dhama K, Nainu F, Frediansyah A, Yatoo MI, Mohapatra RK, Chakraborty S, Zhou H, Islam MR, Mamada SS, Kusuma HI, Rabaan AA, Alhumaid S, Mutair AA, Iqhrammullah M, Al-Tawfiq JA, Mohaini MA, Alsalman AJ, Tuli HS, Chakraborty C, Harapan H. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health 2023;16:4-14. [PMID: 36446204 DOI: 10.1016/j.jiph.2022.11.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
74 Li M, Hao J, Jiang T, Deng W, Lu H, Wang S, Wan G, Xie Y, Yi W. Maternal and neonatal safety of COVID-19 vaccination during the peri-pregnancy period: A prospective study. J Med Virol 2023;95:e28378. [PMID: 36478410 DOI: 10.1002/jmv.28378] [Reference Citation Analysis]
75 Li X, Li J, Zhou P, Li D, Wang M, Tong Q, Chen J, Zuo C, Zhang L, Li R. The functional views on response of host rabbit post coronavirus vaccination via ACE2 PET. Am J Nucl Med Mol Imaging 2023;13:43-50. [PMID: 36923599] [Reference Citation Analysis]
76 Mamani-Benito O, Farfán-Solís R, Huayta-Meza M, Tito-Betancur M, Morales-García WC, Tarqui EEA. Effect of religious fatalism and concern about new variants on the acceptance of COVID-19 vaccines. Front Psychiatry 2023;14:1071543. [PMID: 36937730 DOI: 10.3389/fpsyt.2023.1071543] [Reference Citation Analysis]
77 Barroso-Arévalo S, Díaz-Frutos M, Kosowska A, Pérez-Sancho M, Domínguez L, Sánchez-Vizcaíno JM. A useful tool for the safe diagnosis and control of the two main pandemics of the XXI century: COVID-19 and African Swine Fever disease. PLoS One 2023;18:e0282632. [PMID: 36877705 DOI: 10.1371/journal.pone.0282632] [Reference Citation Analysis]
78 Tomioka K, Uno K, Yamada M. Association between vaccination status and COVID-19-related health outcomes among community-dwelling COVID-19 patients in Nara, Japan. Environ Health Prev Med 2023;28:7. [PMID: 36682815 DOI: 10.1265/ehpm.22-00199] [Reference Citation Analysis]
79 Yin Y, Zeng T, Lai M, Luan Z, Wang K, Ma Y, Hu Z, Wang K, Peng Z. Impact of antibody-level on viral shedding in B.1.617.2 (Delta) variant-infected patients analyzed using a joint model of longitudinal and time-to-event data. MBE 2023;20:8875-8891. [DOI: 10.3934/mbe.2023390] [Reference Citation Analysis]
80 Wang M, Liu Z, Wang Z, Li K, Tian Y, Lu W, Hong J, Peng X, Shi J, Zhang Z, Mei G. Clinical characteristics of 1139 mild cases of the SARS-CoV-2 Omicron variant infected patients in Shanghai. J Med Virol 2023;95:e28224. [PMID: 36238984 DOI: 10.1002/jmv.28224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Sandoval C, Guerrero D, Muñoz J, Godoy K, Souza-Mello V, Farías J. Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review. Expert Rev Vaccines 2023;22:35-53. [PMID: 36484136 DOI: 10.1080/14760584.2023.2156861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Mishra S, Kuru Cİ, Ulucan-karnak F. Nanotechnology and materials science help fight against SARS-CoV-2. Smart Nanomaterials to Combat the Spread of Viral Infections 2023. [DOI: 10.1016/b978-0-323-99148-3.00005-4] [Reference Citation Analysis]
83 Kostaki EG, Mossialos E, Tseti I, Sfikakis PP, Paraskevis D. Mapping the Early Dispersal Patterns of SARS-CoV-2 Omicron BA.4 and BA.5 Subvariants in the Absence of Travel Restrictions and Testing at the Borders in Europe. Viruses 2022;15:133. [PMID: 36680171 DOI: 10.3390/v15010133] [Reference Citation Analysis]
84 Burrowes SAB, Casey SM, Dobbins S, Hall T, Ma M, Bano R, Drainoni ML, Schechter-Perkins EM, Garofalo C, Perkins RB, Pierre-Joseph N. Healthcare workers' perspectives on the COVID-19 vaccine and boosters for themselves, their patients, and their communities: a mixed methods study. Z Gesundh Wiss 2022;:1-14. [PMID: 36588660 DOI: 10.1007/s10389-022-01793-1] [Reference Citation Analysis]
85 Mai NT, Tran GTH, Dang AH, Cao PTB, Nguyen TT, Pham HTL, Vu TTT, Dong HV, Huynh LTM. Comparison of the Basic Reproduction Numbers for COVID-19 through Four Waves of the Pandemic in Vietnam. IJTM 2022;3:1-11. [DOI: 10.3390/ijtm3010001] [Reference Citation Analysis]
86 Liang Z, Tian Y, Wang Y, Zhao J, Guo R, Qiu X, Lan J, Sun X, Liu Y, Liu S. Predicting incidence density of COVID-19 rebound using tree-based machine learning algorithms.. [DOI: 10.21203/rs.3.rs-2383827/v1] [Reference Citation Analysis]
87 Śliż D, Wiecha S, Gąsior JS, Kasiak PS, Ulaszewska K, Postuła M, Małek ŁA, Mamcarz A. The Influence of Nutrition and Physical Activity on Exercise Performance after Mild COVID-19 Infection in Endurance Athletes-CESAR Study. Nutrients 2022;14. [PMID: 36558540 DOI: 10.3390/nu14245381] [Reference Citation Analysis]
88 Santos ACF, Martel F, Freire CSR, Ferreira BJML. Polymeric Materials as Indispensable Tools to Fight RNA Viruses: SARS-CoV-2 and Influenza A. Bioengineering (Basel) 2022;9. [PMID: 36551022 DOI: 10.3390/bioengineering9120816] [Reference Citation Analysis]
89 Lai YH, Chen HY, Chiu HH, Kang YN, Wong SB. Peripheral Nervous System Adverse Events after the Administration of mRNA Vaccines: A Systematic Review and Meta-Analysis of Large-Scale Studies. Vaccines (Basel) 2022;10. [PMID: 36560584 DOI: 10.3390/vaccines10122174] [Reference Citation Analysis]
90 Federica Centofanti, Tonino Alonzi, Andrea Latini, Paola Spitalieri, Michela Murdocca, Xiaodong Chen, Weibo Cui, Qianwen Shang, Delia Goletti, Yufang Shi, Andrea Duranti, Carlo Tomino, Michela Biancolella, Federica Sangiuolo, Maria Rosaria Capobianchi, Suresh Jain, Giuseppe Novelli, Pier Paolo Pandolfi. Indole-3-carbinol in vitro antiviral activity against SARS-Cov-2 virus and in vivo toxicity. Cell Death Discov 2022;8:491. [PMID: 36522315 DOI: 10.1038/s41420-022-01280-2] [Reference Citation Analysis]
91 Álvarez-Díaz DA, Muñoz AL, Herrera-Sepúlveda MT, Tavera-Rodríguez P, Laiton-Donato K, Franco-Muñoz C, Ruiz-Moreno HA, Galindo M, Catama JD, Bermudez-Forero A, Mercado-Reyes M. Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia. Vaccines (Basel) 2022;10. [PMID: 36560554 DOI: 10.3390/vaccines10122144] [Reference Citation Analysis]
92 Bisen SS, Zeiser LB, Boyarsky B, Werbel W, Snyder J, Garonzik-Wang J, Levan ML, Segev DL, Massie AB. Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States. Transplant Direct 2023;9:e1423. [PMID: 36582674 DOI: 10.1097/TXD.0000000000001423] [Reference Citation Analysis]
93 Fujimoto K, Mutsuo S, Yasuda Y, Arasawa S, Tashima N, Iwashima D, Takahashi KI. Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants. Infect Dis Rep 2022;14:996-1003. [PMID: 36547245 DOI: 10.3390/idr14060099] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Gao S, Song L, Claff T, Woodson M, Sylvester K, Jing L, Weiße RH, Cheng Y, Sträter N, Schäkel L, Gütschow M, Ye B, Yang M, Zhang T, Kang D, Toth K, Tavis J, Tollefson AE, Müller CE, Zhan P, Liu X. Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors. J Med Chem 2022;65:16902-17. [PMID: 36475694 DOI: 10.1021/acs.jmedchem.2c01716] [Reference Citation Analysis]
95 Han H, Zhao D, Fang X, Yang W, Wang M, Liu Q, Wang L, Ji Z, Zhang J, Hou Z, Hua L, Wang Y, Wu L. A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson's disease.. [DOI: 10.21203/rs.3.rs-2152063/v2] [Reference Citation Analysis]
96 Mara E, Mader T, Gratzer J, Hochegger S, Pekar T. SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria. Clinical Immunology Communications 2022;2:136-141. [DOI: 10.1016/j.clicom.2022.08.001] [Reference Citation Analysis]
97 Karami H, Karimi Z, Karami N. SARS-CoV-2 in brief: from virus to prevention. Osong Public Health Res Perspect 2022;13:394-406. [PMID: 36617546 DOI: 10.24171/j.phrp.2022.0155] [Reference Citation Analysis]
98 Regazzi L, Marziali E, Lontano A, Villani L, Paladini A, Calabrò GE, Laurenti P, Ricciardi W, Cadeddu C. Knowledge, attitudes, and behaviors toward COVID-19 vaccination in a sample of Italian healthcare workers. Hum Vaccin Immunother 2022;18:2116206. [PMID: 36197125 DOI: 10.1080/21645515.2022.2116206] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Shi X, Zhang Y, Zhou L, Zhou L, Qiao H. Influenza vaccination coverage among health-care workers during the COVID-19 epidemic in 2020/2021 influenza season: Evidence from a web-based survey in northwestern China. Hum Vaccin Immunother 2022;18:2102354. [PMID: 35920744 DOI: 10.1080/21645515.2022.2102354] [Reference Citation Analysis]
100 Feng Y, Quan Y, Cassady K, Zou Z, Gao Y, Zhang X. Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination. Hum Vaccin Immunother 2022;18:2119043. [PMID: 36069667 DOI: 10.1080/21645515.2022.2119043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
101 Collatuzzo G, Lodi V, Feola D, De Palma G, Sansone E, Sala E, Janke C, Castelletti N, Porru S, Spiteri G, Monaco MGL, Larese Filon F, Negro C, Cegolon L, Beresova J, Fabianova E, Carrasco-Ribelles LA, Toràn-Monserrat P, Rodriguez-Suarez MM, Fernandez-Tardon G, Asafo SS, Ditano G, Abedini M, Boffetta P. Determinants of Anti-S Immune Response at 9 Months after COVID-19 Vaccination in a Multicentric European Cohort of Healthcare Workers-ORCHESTRA Project. Viruses 2022;14. [PMID: 36560660 DOI: 10.3390/v14122657] [Reference Citation Analysis]
102 Bouwmans P, Messchendorp AL, Imhof C, Sanders JF, Hilbrands LB, Reinders MEJ, Vart P, Bemelman FJ, Abrahams AC, van den Dorpel RMA, Ten Dam MAGJ, de Vries APJ, Rispens T, Steenhuis M, Gansevoort RT, Hemmelder MH; RECOVAC Collaborators. Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy. Clin Kidney J 2023;16:528-40. [PMID: 36865021 DOI: 10.1093/ckj/sfac249] [Reference Citation Analysis]
103 Heinzl MW, Kolenchery L, Resl M, Klammer C, Black A, Obendorf F, Schinagl L, Feldbauer R, Pohlhammer J, Wagner T, Berger T, Dieplinger B, Clodi M. High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection. Int J Environ Res Public Health 2022;19. [PMID: 36497655 DOI: 10.3390/ijerph192315581] [Reference Citation Analysis]
104 Ambrogio F, Laface C, Sbarra G, Filotico R, Ranieri G, Barlusconi C, De Marco A, Cazzato G, Bonamonte D, Romita P, Foti C. A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association? Vaccines 2022;10:1972. [DOI: 10.3390/vaccines10111972] [Reference Citation Analysis]
105 Percio J, Cabral CM, Fantinato FFST, de Assis DM, Guzmán-Barrera LS, de Araújo WN. Effect of vaccination against Covid-19 one year after its introduction in Brazil. Trop Dis Travel Med Vaccines 2022;8:25. [PMID: 36401301 DOI: 10.1186/s40794-022-00183-5] [Reference Citation Analysis]
106 Trivedi VS, Magnusen AF, Rani R, Marsili L, Slavotinek AM, Prows DR, Hopkin RJ, McKay MA, Pandey MK. Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy. Int J Mol Sci 2022;23. [PMID: 36430817 DOI: 10.3390/ijms232214340] [Reference Citation Analysis]
107 Fiorino S, Carusi A, Hong W, Cernuschi P, Gallo CG, Ferrara E, Maloberti T, Visani M, Lari F, de Biase D, Zippi M. SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses. AIMS Microbiol 2022;8:422-53. [PMID: 36694588 DOI: 10.3934/microbiol.2022029] [Reference Citation Analysis]
108 Wang Z, An J, Liu K, Yu P, Fang X, Li J, Zhu H, Zhu Q, Huang C, Zhang C, Zhao B, Bao L, Song Y, Cao X, Hu D, Jiang Y, Shi L, Zhou L, Fan J, Guan W, Zhou C, Hu Z, Yuan Z, Liu J, Shan C, Liu G. A potent, broadly protective vaccine against SARS-CoV-2 variants of concern. npj Vaccines 2022;7:144. [DOI: 10.1038/s41541-022-00571-0] [Reference Citation Analysis]
109 Charland N, Gobeil P, Pillet S, Boulay I, Séguin A, Makarkov A, Heizer G, Bhutada K, Mahmood A, Trépanier S, Hager K, Jiang-wright J, Atkins J, Saxena P, Cheng MP, Vinh DC, Boutet P, Roman F, Van Der Most R, Ceregido MA, Dionne M, Tellier G, Gauthier J, Essink B, Libman M, Haffizulla J, Fréchette A, D’aoust M, Landry N, Ward BJ. Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities. npj Vaccines 2022;7:142. [DOI: 10.1038/s41541-022-00561-2] [Reference Citation Analysis]
110 Liu Y, Zhao D, Wang Y, Chen Z, Yang L, Li W, Gong Y, Gan C, Tang J, Zhang T, Tang D, Dong X, Yang Q, Valencia CA, Dai L, Qi S, Dong B, Chow HY, Li Y. A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1011484] [Reference Citation Analysis]
111 Alcolea PJ, Larraga J, Rodríguez-martín D, Alonso A, Loayza FJ, Rojas JM, Ruiz-garcía S, Louloudes-lázaro A, Carlón AB, Sánchez-cordón PJ, Nogales-altozano P, Redondo N, Manzano M, Lozano D, Palomero J, Montoya M, Vallet-regí M, Martín V, Sevilla N, Larraga V. Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1023255] [Reference Citation Analysis]
112 Lu J, Meng M, Zhou X, Ding S, Feng K, Zeng Z, Huang T, Cai Y. Identification of COVID-19 severity biomarkers based on feature selection on single-cell RNA-Seq data of CD8+ T cells. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1053772] [Reference Citation Analysis]
113 Acosta-Altamirano G, Garduño-Javier E, Hernández-Gómez V, Espinosa JA, Vaca-Paniagua F, Rodríguez-Sosa M, Juárez-Avelar I, Terrazas LI, Bravata-Alcántara JC, Sierra-Martínez M, Olguín JE. Dual activation profile of monocytes is associated with protection in Mexican patients during SARS-CoV-2 disease. Appl Microbiol Biotechnol 2022. [PMID: 36342507 DOI: 10.1007/s00253-022-12256-8] [Reference Citation Analysis]
114 Akarapipad P, Bertelson E, Pessell A, Wang T, Hsieh K. Emerging Multiplex Nucleic Acid Diagnostic Tests for Combating COVID-19. Biosensors 2022;12:978. [DOI: 10.3390/bios12110978] [Reference Citation Analysis]
115 Kim S, Willis E, Wehlage S, Scheffer-wentz H, Dulitz M. COVID-19 vaccine hesitancy and short-term and long-term intentions among unvaccinated young adults: a mixed-method approach. BMC Public Health 2022;22:2030. [DOI: 10.1186/s12889-022-14448-3] [Reference Citation Analysis]
116 Mezhenskaya DА, Isakova-sivak IN, Rudenko LG. Assessment of cell-mediated immune responses to SARS-CoV-2 in Syrian hamsters. Medical academic journal 2022;2:215-220. [DOI: 10.17816/maj108629] [Reference Citation Analysis]
117 Tanriover MD, Aydin OA, Guner R, Yildiz O, Celik I, Doganay HL, Kose S, Akhan S, Akalin EH, Sezer Z, Ozdarendeli A, Unal S, on behalf of the TURKOVAC Study Group. Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial. Vaccines 2022;10:1865. [DOI: 10.3390/vaccines10111865] [Reference Citation Analysis]
118 Zhang H, Wu Y, Wang N, Sun X, Wang Y, Zhang Y. Caregivers' experiences and perspectives on caring for the elderly during the COVID-19 pandemic: A qualitative systematic review. J Nurs Manag 2022;30:3972-95. [PMID: 36208194 DOI: 10.1111/jonm.13859] [Reference Citation Analysis]
119 Genzor S, Prasko J, Mizera J, Jakubec P, Sova M, Vanek J, Šurinová N, Langova K. Risk of Severe COVID-19 in Non-Adherent OSA Patients. PPA 2022;Volume 16:3069-3079. [DOI: 10.2147/ppa.s387657] [Reference Citation Analysis]
120 Li YE, Wang S, Reiter RJ, Ren J. Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality? Int J Infect Dis 2022;124:1-10. [PMID: 36075372 DOI: 10.1016/j.ijid.2022.08.026] [Reference Citation Analysis]
121 Almeida M, Lavado P, Cunha L, Cordeiro I, Baptista A. Invasive Pneumococcal Disease and COVID-19 Coinfection: A Series of Cases Admitted to an Intensive Care Unit. Cureus 2022;14:e31876. [PMID: 36579230 DOI: 10.7759/cureus.31876] [Reference Citation Analysis]
122 Como N, Mechili EA, Qato M, Meta E, Strakosha A, Fico A, Kenga A, Patelarou AE, Patelarou E. Severity and Mortality Predictors of COVID-19 Patients with Thrombotic Events-Evidence from the "COVID-One" Hospital in Albania. Vaccines (Basel) 2022;10. [PMID: 36366360 DOI: 10.3390/vaccines10111851] [Reference Citation Analysis]
123 Kotsiou OS, Karakousis N, Papagiannis D, Matsiatsiou E, Avgeri D, Fradelos EC, Siachpazidou DI, Perlepe G, Miziou A, Kyritsis A, Gogou E, Vavougios GD, Kalantzis G, Gourgoulianis KI. The Comparative Superiority of SARS-CoV-2 Antibody Response in Different Immunization Scenarios. J Pers Med 2022;12. [PMID: 36573718 DOI: 10.3390/jpm12111756] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Tokuyama-toda R, Terada-ito C, Muraoka M, Horiuchi T, Amemiya T, Fukuoka A, Hamada Y, Takebe Y, Ogawa T, Fujii S, Kikuta T, Sejima S, Satomura K. Improving the Detection Sensitivity of a New Rapid Diagnostic Technology for Severe Acute Respiratory Syndrome Coronavirus 2 Using a Trace Amount of Saliva. Diagnostics 2022;12:2568. [DOI: 10.3390/diagnostics12112568] [Reference Citation Analysis]
125 Han H, Zhao D, Fang X, Yang W, Wang M, Liu Q, Wang L, Ji Z, Zhang J, Hou Z, Hua L, Wang Y, Wu L. Safety and status report of SARS-CoV-2 vaccination in patients with Wilson's disease.. [DOI: 10.21203/rs.3.rs-2152063/v1] [Reference Citation Analysis]
126 Islas-Vazquez L, Cruz-Aguilar M, Velazquez-Soto H, Jiménez-Corona A, Pérez-Tapia SM, Jimenez-Martinez MC. Effector-Memory B-Lymphocytes and Follicular Helper T-Lymphocytes as Central Players in the Immune Response in Vaccinated and Nonvaccinated Populations against SARS-CoV-2. Vaccines (Basel) 2022;10. [PMID: 36298626 DOI: 10.3390/vaccines10101761] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Zhang M, Zhang P, Liang Y, Du B, Li L, Yu Z, Wang H, Wang Q, Zhang X, Zhang W. A systematic review of current status and challenges of vaccinating children against SARS-CoV-2. J Infect Public Health 2022;15:1212-24. [PMID: 36257126 DOI: 10.1016/j.jiph.2022.10.006] [Reference Citation Analysis]
128 Tang SGH, Hadi MHH, Arsad SR, Ker PJ, Ramanathan S, Afandi NAM, Afzal MM, Yaw MW, Krishnan PS, Chen CP, Tiong SK. Prerequisite for COVID-19 Prediction: A Review on Factors Affecting the Infection Rate. Int J Environ Res Public Health 2022;19. [PMID: 36293576 DOI: 10.3390/ijerph192012997] [Reference Citation Analysis]
129 Mohseni Afshar Z, Tavakoli Pirzaman A, Liang JJ, Sharma A, Pirzadeh M, Babazadeh A, Hashemi E, Deravi N, Abdi S, Allahgholipour A, Hosseinzadeh R, Vaziri Z, Sio TT, Sullman MJM, Barary M, Ebrahimpour S. Do we miss rare adverse events induced by COVID-19 vaccination? Front Med (Lausanne) 2022;9:933914. [PMID: 36300183 DOI: 10.3389/fmed.2022.933914] [Reference Citation Analysis]
130 Chua XH, Lin WL, Lee YT. Adult-Onset Still's Disease following Coronavirus 2 (SARS-CoV-2) Vaccination: A Case Report. Vaccines (Basel) 2022;10:1687. [PMID: 36298552 DOI: 10.3390/vaccines10101687] [Reference Citation Analysis]
131 Delshad M, Sanaei MJ, Pourbagheri-Sigaroodi A, Bashash D. Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination. Int Immunopharmacol 2022;111:109128. [PMID: 35963158 DOI: 10.1016/j.intimp.2022.109128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
132 Yee D, Khan S, Zagona-prizio C, Maynard N, Reddy R, Khan S, Mehta M, Armstrong AW. Public Perception of SARS-CoV-2 Vaccines Among Psoriasis Patients in Social Media: Content, Sentiment, and Engagement Analysis. Journal of Psoriasis and Psoriatic Arthritis 2022;7:164-173. [DOI: 10.1177/24755303221110095] [Reference Citation Analysis]
133 Collatuzzo G, Visci G, Violante FS, Porru S, Spiteri G, Monaco MGL, Larese Fillon F, Negro C, Janke C, Castelletti N, De Palma G, Sansone E, Mates D, Teodorescu S, Fabiánová E, Bérešová J, Vimercati L, Tafuri S, Abedini M, Ditano G, Asafo SS, Boffetta P; Orchestra WP5 Working Group. Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers – ORCHESTRA project. Front Immunol 2022;13:986085. [DOI: 10.3389/fimmu.2022.986085] [Reference Citation Analysis]
134 Rudi E, Martin Aispuro P, Zurita E, Gonzalez lopez Ledesma M, Bottero D, Malito J, Gabrielli M, Gaillard E, Stuible M, Durocher Y, Gamarnik A, Wigdorovitz A, Hozbor D. Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern. Front Immunol 2022;13:1020159. [DOI: 10.3389/fimmu.2022.1020159] [Reference Citation Analysis]
135 Li X, Liang W, Yu C, Meng Q, Zhang W, Wu X, Xue J, Deng S, Wang H. Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19. Front Pharmacol 2022;13:988153. [DOI: 10.3389/fphar.2022.988153] [Reference Citation Analysis]
136 Chi X, Gu J, Ma X. Characteristics and Roles of T Follicular Helper Cells in SARS-CoV-2 Vaccine Response. Vaccines 2022;10:1623. [DOI: 10.3390/vaccines10101623] [Reference Citation Analysis]
137 D’apice L, Trovato M, Gramigna G, Colavita F, Francalancia M, Matusali G, Meschi S, Lapa D, Bettini A, Mizzoni K, Aurisicchio L, Di Caro A, Castilletti C, De Berardinis P. Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay. Front Immunol 2022;13:981693. [DOI: 10.3389/fimmu.2022.981693] [Reference Citation Analysis]
138 Maltoni G, Scutteri L, Mensitieri F, Piaz FD, Hochkoeppler A. High-yield production in Escherichia coli and convenient purification of a candidate vaccine against SARS-CoV-2. Biotechnol Lett 2022. [PMID: 36161539 DOI: 10.1007/s10529-022-03298-z] [Reference Citation Analysis]
139 Li X, Xu Y, Li X, Liu W, Yao D, Chen W, Yu H, He L, Lu S, Jiang C, Zhu W, Meng L. Real-world effectiveness and protection of SARS-CoV-2 vaccine among patients hospitalized for COVID-19 in Xi’an, China, December 8, 2021, to January 20, 2022: A retrospective study. Front Immunol 2022;13:978977. [DOI: 10.3389/fimmu.2022.978977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Negroni D, Carriero S, Passarella I, Siani A, Biondetti P, Pizzolante A, Saba L, Guzzardi G. Preliminary Analysis of the Effects of Ad26.COV2.S Vaccination on CT Findings and High Intensive Care Admission Rates of COVID-19 Patients. Tomography 2022;8:2403-2410. [DOI: 10.3390/tomography8050199] [Reference Citation Analysis]
141 He Y, Yu W, Shen L, Yan W, Xiao L, Qi J, Hu T. A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan. Int J Biol Macromol 2022;222:661-70. [PMID: 36152702 DOI: 10.1016/j.ijbiomac.2022.09.180] [Reference Citation Analysis]
142 Chen YL, Lin JJ, Ma H, Zhong N, Xie XX, Yang Y, Zheng P, Zhang LJ, Jin T, Cao MJ. Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein. Int J Mol Sci 2022;23:10904. [PMID: 36142819 DOI: 10.3390/ijms231810904] [Reference Citation Analysis]
143 Mirmosayyeb O, Moases Ghaffary E, Mazdak M, Bagheri Z, Bagherieh S, Shaygannejad V. Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review. Canadian Journal of Infectious Diseases and Medical Microbiology 2022;2022:1-7. [DOI: 10.1155/2022/5009450] [Reference Citation Analysis]
144 Hong SA. Six Pivotal Lessons Learned in South Korea for Whole-of-Government Approach to Successful COVID-19 Vaccine Rollout in Planetary Health. OMICS: A Journal of Integrative Biology 2022. [DOI: 10.1089/omi.2022.0064] [Reference Citation Analysis]
145 Matsumura Y, Yamamoto M, Shinohara K, Tsuchido Y, Yukawa S, Noguchi T, Ikeda T, Nagao M. High mortality and morbidity among vaccinated residents infected with the SARS-CoV-2 Omicron variant during an outbreak in a nursing home in Kyoto City, Japan. Am J Infect Control 2022:S0196-6553(22)00675-7. [PMID: 36116676 DOI: 10.1016/j.ajic.2022.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Yu S, He Y, Ji W, Yang R, Zhao Y, Li Y, Liu Y, Ding L, Ma M, Wang H, Yang X. Metabolic and Proteomic Profiles Associated with Immune Responses Induced by Different Inactivated SARS-CoV-2 Vaccine Candidates. IJMS 2022;23:10644. [DOI: 10.3390/ijms231810644] [Reference Citation Analysis]
147 Cristina Diaconu C, Madalina Pitica I, Chivu-economescu M, Georgiana Necula L, Botezatu A, Virginia Iancu I, Iulia Neagu A, L. Radu E, Matei L, Maria Ruta S, Bleotu C. SARS-CoV-2 Variant Surveillance in Genomic Medicine Era. Infectious Diseases 2022. [DOI: 10.5772/intechopen.107137] [Reference Citation Analysis]
148 Fernandes CM, Dias SL, Ferreira MC, Luna EJA. COVID-19 post-vaccination in healthcare workers and vaccine effectiveness, Brazil, 2021. Clinics (Sao Paulo) 2022;77:100109. [PMID: 36179526 DOI: 10.1016/j.clinsp.2022.100109] [Reference Citation Analysis]
149 Sun J, Ma X, Zhang M, Xie M, Zhang X, Han X, Li X, Zhou E, Wang J, She D, Wang J. Comparisons of lymphocytes profiles and inflammatory cytokines levels in blood of patients with differed severity of infection by human adenovirus type 7 Running title: HAdV-7 infection and immune dysfunction.. [DOI: 10.21203/rs.3.rs-2017183/v1] [Reference Citation Analysis]
150 Kanokudom S, Chansaenroj J, Suntronwong N, Assawakosri S, Yorsaeng R, Nilyanimit P, Aeemjinda R, Khanarat N, Vichaiwattana P, Klinfueng S, Thongmee T, Katanyutanon A, Thanasopon W, Arayapong J, Withaksabut W, Srimuan D, Thatsanatorn T, Sudhinaraset N, Wanlapakorn N, Honsawek S, Poovorawan Y. Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax™) after homologous and heterologous two-dose regimens.. [DOI: 10.1101/2022.09.07.22279684] [Reference Citation Analysis]
151 da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, de Magalhães JJF, Vigar JRJ, Silva-Júnior A, Kohl A, Pardee K, Pena L. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis 2022;8:1758-814. [PMID: 35940589 DOI: 10.1021/acsinfecdis.2c00204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
152 Kasman LM. Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine. Front Immunol 2022;13:871463. [DOI: 10.3389/fimmu.2022.871463] [Reference Citation Analysis]
153 Zong X, Wang X, Liu Y, Li Z, Wang W, Wei D, Chen Z. Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials. Front Med 2022;9. [DOI: 10.3389/fmed.2022.965790] [Reference Citation Analysis]
154 Zhong W, Jiang X, Yang X, Feng T, Duan Z, Wang W, Sun Z, Chen L, Nie X, Zhu C, Zhang W, Li Y. The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial. Front Med 2022;9. [DOI: 10.3389/fmed.2022.980002] [Reference Citation Analysis]
155 Jonny J, Putranto TA, Irfon R, Sitepu EC. Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic. Front Immunol 2022;13:989685. [DOI: 10.3389/fimmu.2022.989685] [Reference Citation Analysis]
156 Najafi-fard S, Petruccioli E, Farroni C, Petrone L, Vanini V, Cuzzi G, Salmi A, Altera AMG, Navarra A, Alonzi T, Nicastri E, Palmieri F, Gualano G, Carlini V, Noonan DM, Albini A, Goletti D. Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy. Front Immunol 2022;13:984098. [DOI: 10.3389/fimmu.2022.984098] [Reference Citation Analysis]
157 Kim YE, Huh K, Park YJ, Peck KR, Jung J. Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection. JAMA 2022;328:887-9. [PMID: 35867050 DOI: 10.1001/jama.2022.12992] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 23.0] [Reference Citation Analysis]
158 Tan J, Wu Z, Hu P, Gan L, Wang Y, Zhang D. Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes. Pathogens 2022;11:1008. [PMID: 36145442 DOI: 10.3390/pathogens11091008] [Reference Citation Analysis]
159 Alimohammadi R, Porgoo M, Eftekhary M, Kiaie SH, Ansari Dezfouli E, Dehghani M, Nasrollahi K, Malekshahabi T, Heidari M, Pouya S, Alimohammadi M, Sattari Khavas D, Modaresi MS, Ghasemi MH, Ramyar H, Mohammadipour F, Hamzelouei F, Mofayezi A, Mottaghi SS, Rahmati A, Razzaznian M, Tirandazi V, Tat M, Borzouee F, Sadeghi H, Haji Mohammadi M, Rastegar L, Safar Sajadi SM, Ehsanbakhsh H, Bazmbar H, Baghernejadan Z, Shams Nouraei M, Pazooki P, Pahlavanneshan M, Alishah K, Nasiri F, Mokhberian N, Mohammadi SS, Akar S, Niknam H, Azizi M, Ajoudanian M, Moteallehi-Ardakani MH, Mousavi Shaegh SA, Ramezani R, Salimi V, Moazzami R, Hashemi SM, Dehghanizadeh S, Khoddami V. SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates. NPJ Vaccines 2022;7:105. [PMID: 36056015 DOI: 10.1038/s41541-022-00528-3] [Reference Citation Analysis]
160 Morales-Hernández S, Ugidos-Damboriena N, López-Sagaseta J. Self-Assembling Protein Nanoparticles in the Design of Vaccines: 2022 Update. Vaccines (Basel) 2022;10:1447. [PMID: 36146525 DOI: 10.3390/vaccines10091447] [Reference Citation Analysis]
161 Kladar N, Bijelić K, Gatarić B, Bubić Pajić N, Hitl M. Phytotherapy and Dietotherapy of COVID-19—An Online Survey Results from Central Part of Balkan Peninsula. Healthcare 2022;10:1678. [DOI: 10.3390/healthcare10091678] [Reference Citation Analysis]
162 Abdolmaleki G, Taheri MA, Paridehpour S, Mohammadi NM, Tabatabaei YA, Mousavi T, Amin M. A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines. DARU J Pharm Sci 2022. [DOI: 10.1007/s40199-022-00446-8] [Reference Citation Analysis]
163 Wei Y, Wang Y, Liu L, Zha Y, Yang Y, Wang Y, Roberts N, Li Y. Analysis of Adverse Effects of COVID-19 Vaccines Experienced by Healthcare Workers at Guizhou Provincial Staff Hospital, China. Vaccines (Basel) 2022;10. [PMID: 36146526 DOI: 10.3390/vaccines10091449] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
164 Christian J, Lanzkron S, Naik RP. COVID-19 outcomes in sickle cell disease and sickle cell trait. Best Pract Res Clin Haematol 2022;35:101382. [PMID: 36494153 DOI: 10.1016/j.beha.2022.101382] [Reference Citation Analysis]
165 Dias VMDCH, Oliveira AF, Marinho AKBB, Santos Ferreira CED, Domingues CEF, Fortaleza CMCB, Vidal CFDL, Carrilho CMDDM, Pinheiro DOBP, de Assis DB, Medeiros EA, Morejón KML, Weissmann L, Michelin L, Carneiro M, Nogueira MDSDP, de Oliveira PRD, Buralli RJ, Stucchi RSB, Lins RS, Costa SF, Chebabo A. COVID-19 and isolation: Risks and implications in the scenario of new variants. The Brazilian Journal of Infectious Diseases 2022;26:102703. [DOI: 10.1016/j.bjid.2022.102703] [Reference Citation Analysis]
166 Le Gars M, Hendriks J, Sadoff J, Ryser M, Struyf F, Douoguih M, Schuitemaker H. Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine. Immunol Rev 2022;310:47-60. [PMID: 35689434 DOI: 10.1111/imr.13088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
167 Roy D, Rahman MM, Chaity AS, Reza MA, Haque A. Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population. Sci Rep 2022;12:14681. [PMID: 36038600 DOI: 10.1038/s41598-022-18302-9] [Reference Citation Analysis]
168 Huang J, Zhang MQ, Huang MZ, Lin GM. The Actual Status of Hospitals as COVID-19 Vaccination Clinics in China and Safety Monitoring of Inactivated Vaccine: A Cross-Sectional Study. Disaster Med Public Health Prep 2022;17:e256. [PMID: 36017705 DOI: 10.1017/dmp.2022.217] [Reference Citation Analysis]
169 Hou YC, Wu CL, Lu KC, Kuo KL. Indoxyl Sulfate Alters the Humoral Response of the ChAdOx1 COVID-19 Vaccine in Hemodialysis Patients. Vaccines (Basel) 2022;10. [PMID: 36146454 DOI: 10.3390/vaccines10091378] [Reference Citation Analysis]
170 Biselli R, Nisini R, Lista F, Autore A, Lastilla M, De Lorenzo G, Peragallo MS, Stroffolini T, D’amelio R. A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health. Biomedicines 2022;10:2050. [DOI: 10.3390/biomedicines10082050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Ferrara P, Ponticelli D, Magliuolo R, Borrelli M, Schiavone B, Mantovani LG. Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study. Vaccines (Basel) 2022;10:1353. [PMID: 36016240 DOI: 10.3390/vaccines10081353] [Reference Citation Analysis]
172 Campos DMO, Silva MKD, Barbosa ED, Leow CY, Fulco UL, Oliveira JIN. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants. Comput Biol Chem 2022;101:107754. [PMID: 36037724 DOI: 10.1016/j.compbiolchem.2022.107754] [Reference Citation Analysis]
173 Brehm J, Spaeth A, Dreßler L, Masetto T, Dannenberg R, Peter C, Grimmler M. SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study. Front Immunol 2022;13:915338. [DOI: 10.3389/fimmu.2022.915338] [Reference Citation Analysis]
174 Caputo E, Mandrich L. Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants. Life (Basel) 2022;12:1245. [PMID: 36013424 DOI: 10.3390/life12081245] [Reference Citation Analysis]
175 Zee ST, Kwok LF, Kee KM, Fung LH, Luk WP, Chan TL, Leung CP, Yu PW, Hung J, SzeTo KY, Chan WL, Tang SF, Lin WC, Ma SK, Lee KH, Lau CC, Yung WH. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong. Vaccines (Basel) 2022;10. [PMID: 36016210 DOI: 10.3390/vaccines10081322] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Md Khairi LNH, Fahrni ML, Lazzarino AI. The Race for Global Equitable Access to COVID-19 Vaccines. Vaccines (Basel) 2022;10:1306. [PMID: 36016194 DOI: 10.3390/vaccines10081306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
177 Alsafi RT. Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far. Canadian Journal of Infectious Diseases and Medical Microbiology 2022;2022:1-13. [DOI: 10.1155/2022/1156273] [Reference Citation Analysis]
178 Voulgaridi I, Sarrou S, Dadouli A, Peristeri AM, Nasika A, Onoufriadis I, Kyritsi MA, Anagnostopoulos L, Theodoridou A, Avakian I, Pappa D, Konstantinou AK, Papadamou G, Mouchtouri VA, Petinaki E, Speletas M, Hadjichristodoulou C. Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines. Vaccines (Basel) 2022;10:1268. [PMID: 36016156 DOI: 10.3390/vaccines10081268] [Reference Citation Analysis]
179 Chen P, Cui Z, Li C, Deng S, Yang H. Establishment of a protein thermal shift chip (PTSC) for COVID-19 and exploration of the future of protein chips in pharmacology. Acta Materia Medica 2022;1. [DOI: 10.15212/amm-2022-0016] [Reference Citation Analysis]
180 Johnson MG, Puenpatom A, Moncada PA, Burgess L, Duke ER, Ohmagari N, Wolf T, Bassetti M, Bhagani S, Ghosn J, Zhang Y, Wan H, Williams-Diaz A, Brown ML, Paschke A, De Anda C. Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial. Ann Intern Med 2022;175:1126-34. [PMID: 35667065 DOI: 10.7326/M22-0729] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 24.0] [Reference Citation Analysis]
181 Matsumura Y, Nagao M, Yamamoto M, Tsuchido Y, Noguchi T, Shinohara K, Yukawa S, Inoue H, Ikeda T. Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021. Emerg Infect Dis 2022;28. [PMID: 35710464 DOI: 10.3201/eid2808.220420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Chen Y, Guo Y, Song Z, Chang H, Kuang Q, Zheng Z, Wang H, Zhang G. Luteolin restricts ASFV replication by regulating the NF-κB/STAT3/ATF6 signaling pathway. Veterinary Microbiology 2022. [DOI: 10.1016/j.vetmic.2022.109527] [Reference Citation Analysis]
183 Zhang Y, Zheng X, Sheng W, Liang H, Zhao Y, Zhu X, Yang R, Zhang Y, Dong X, Li W, Pei F, Ding L, Chang Z, Deng L, Yuan G, Yang Z, Zhu D, Yang X, Wang H. Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants. Vaccines (Basel) 2022;10:1208. [PMID: 36016098 DOI: 10.3390/vaccines10081208] [Reference Citation Analysis]
184 Román LE, Villalva C, Uribe C, Paraguay-delgado F, Sousa J, Vigo J, Vera CM, Gómez MM, Solís JL. Textiles Functionalized with Copper Oxides: A Sustainable Option for Prevention of COVID-19. Polymers 2022;14:3066. [DOI: 10.3390/polym14153066] [Reference Citation Analysis]
185 Liu M, Li Y. Advances in COVID-19 Vaccines and New Coronavirus Variants. Front Med (Lausanne) 2022;9:888631. [PMID: 35872788 DOI: 10.3389/fmed.2022.888631] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Eldokla AM, Numan MT. Postural orthostatic tachycardia syndrome after mRNA COVID-19 vaccine. Clin Auton Res. [DOI: 10.1007/s10286-022-00880-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Abuhammad S, Khabour OF, Alzoubi KH, Hamaideh S, Alzoubi BA, Telfah WS, El-Zubi FK. The public's attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan. PLoS One 2022;17:e0271625. [PMID: 35857813 DOI: 10.1371/journal.pone.0271625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
188 Vokó Z, Kiss Z, Surján G, Surján O, Barcza Z, Wittmann I, Molnár GA, Nagy D, Müller V, Bogos K, Nagy P, Kenessey I, Wéber A, Polivka L, Pálosi M, Szlávik J, Rokszin G, Müller C, Szekanecz Z, Kásler M. Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study). Front Immunol 2022;13:919408. [DOI: 10.3389/fimmu.2022.919408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
189 Feng T, Zhang M, Xu Q, Song F, Wang L, Gai S, Tang H, Wang S, Zhou L, Li H. Exploration of molecular targets and mechanisms of Chinese medicinal formula Acacia Catechu -Scutellariae Radix in the treatment of COVID-19 by a systems pharmacology strategy. Phytother Res 2022. [PMID: 35859316 DOI: 10.1002/ptr.7554] [Reference Citation Analysis]
190 Krakowczyk JB, Bäuerle A, Pape L, Kaup T, Nulle L, Teufel M, Skoda E. COVID-19 Vaccine for Children: Vaccination Willingness of Parents and Its Associated Factors—A Network Analysis. Vaccines 2022;10:1155. [DOI: 10.3390/vaccines10071155] [Reference Citation Analysis]
191 Chavda VP, Sonak SS, Munshi NK, Dhamade PN. Pseudoscience and fraudulent products for COVID-19 management. Environ Sci Pollut Res Int 2022. [PMID: 35836045 DOI: 10.1007/s11356-022-21967-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
192 Zou Y, Huang D, Jiang Q, Guo Y, Chen C. The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis. Front Public Health 2022;10:940956. [DOI: 10.3389/fpubh.2022.940956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
193 Kaplonek P, Deng Y, Lee JS, Zar HJ, Zavadska D, Johnson M, Lauffenburger DA, Goldblatt D, Alter G. Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines.. [DOI: 10.1101/2022.06.28.22276786] [Reference Citation Analysis]
194 Yong S, Halim A, Halim M, Al Mutair A, Alhumaid S, Al-sihati J, Albayat H, Alsaeed M, Garout M, Al Azmi R, Aldakheel N, Alshukairi AN, Al Ali HA, Almoumen AA, Rabaan AA. Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance Studies. Vaccines 2022;10:1067. [DOI: 10.3390/vaccines10071067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Upreti S, Samant M. A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens. Pharm Res 2022. [PMID: 35773445 DOI: 10.1007/s11095-022-03323-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Ennab F, Nawaz FA, Narain K, Nchasi G, Essar MY. Rise of monkeypox: Lessons from COVID-19 pandemic to mitigate global health crises. Ann Med Surg (Lond) 2022;79:104049. [PMID: 35757311 DOI: 10.1016/j.amsu.2022.104049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
197 Tonnara G, Piselli P, Cimaglia C, Arlotti M, Sacchini E, Manoni S, Zani A, Muccioli F, Laderchi A, Rabini S, Antinori A, Vaia F, Nicastri E, Girardi E. The impact of COVID-19 vaccination program in the Republic of San Marino: focus on effectiveness of Gam-COVID-Vac. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.06.026] [Reference Citation Analysis]
198 Duan C, Ma R, Zeng X, Chen B, Hou D, Liu R, Li X, Liu L, Li T, Huang H. SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19. Front Immunol 2022;13:946731. [DOI: 10.3389/fimmu.2022.946731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
199 Ortiz-prado E, Izquierdo-condoy JS, Fernandez-naranjo R, Simbaña-rivera K, Vásconez-gonzález J, Naranjo EPL, Cordovez S, Coronel B, Delgado-moreira K, Jimbo-sotomayor R. A Comparative Analysis of a Self-Reported Adverse Events Analysis after Receiving One of the Available SARS-CoV-2 Vaccine Schemes in Ecuador. Vaccines 2022;10:1047. [DOI: 10.3390/vaccines10071047] [Reference Citation Analysis]
200 Zhao M, Li C, Zhang J, Yin Z, Zheng Z, Wan J, Wang M. Maresin-1 and Its Receptors RORα/LGR6 as Potential Therapeutic Target for Respiratory Diseases. Pharmacol Res 2022;:106337. [PMID: 35781060 DOI: 10.1016/j.phrs.2022.106337] [Reference Citation Analysis]
201 Chaki SP, Kahl-McDonagh MM, Neuman BW, Zuelke KA. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants. Microbiol Spectr 2022;10:e0066522. [PMID: 35638906 DOI: 10.1128/spectrum.00665-22] [Reference Citation Analysis]
202 AlMutairi LT, Alalayet WY, Ata SI, Alenzi KA, AlRuthia Y. Self-Reported COVID-19 Vaccines' Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study. Vaccines (Basel) 2022;10:977. [PMID: 35746586 DOI: 10.3390/vaccines10060977] [Reference Citation Analysis]
203 Richardson VL, Camacho Franco MA, Bautista Márquez A, Martínez Valdez L, Castro Ceronio LE, Cruz Cruz V, Gharpure R, Lafond KE, Yau TS, Azziz-Baumgartner E, Hernández Ávila M. Vaccine Effectiveness of CanSino (Adv5-nCoV) Coronavirus Disease 2019 (COVID-19) Vaccine Among Childcare Workers-Mexico, March-December 2021. Clin Infect Dis 2022;75:S167-73. [PMID: 35717650 DOI: 10.1093/cid/ciac488] [Reference Citation Analysis]
204 Proia E, Ragno A, Antonini L, Sabatino M, Mladenovič M, Capobianco R, Ragno R. Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal. J Comput Aided Mol Des 2022. [PMID: 35716228 DOI: 10.1007/s10822-022-00460-7] [Reference Citation Analysis]
205 Ortega MA, García-montero C, Fraile-martinez O, Colet P, Baizhaxynova A, Mukhtarova K, Alvarez-mon M, Kanatova K, Asúnsolo A, Sarría-santamera A. Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths. JPM 2022;12:995. [DOI: 10.3390/jpm12060995] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
206 Salman A, Elsaddik G, El Mawla Z, Masri R, Hamadeh M, Khatoon A, Saliba MW, Michel Minari A, Hassoun M, Abi Hanna P. The Effectiveness of COVID-19 Vaccines in Preventing Hospitalizations During the Delta Wave: A Patient-Population Study at a Major Referral Center. Cureus 2022. [DOI: 10.7759/cureus.26030] [Reference Citation Analysis]
207 Saberiyan M, Karimi E, Khademi Z, Movahhed P, Safi A, Mehri-Ghahfarrokhi A. SARS-CoV-2: phenotype, genotype, and characterization of different variants. Cell Mol Biol Lett 2022;27:50. [PMID: 35715738 DOI: 10.1186/s11658-022-00352-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
208 Mingot-Castellano ME, Butta N, Canaro M, Gómez Del Castillo Solano MDC, Sánchez-González B, Jiménez-Bárcenas R, Pascual-Izquierdo C, Caballero-Navarro G, Entrena Ureña L, José González-López T, On Behalf Of The Gepti. COVID-19 Vaccines and Autoimmune Hematologic Disorders. Vaccines (Basel) 2022;10:961. [PMID: 35746569 DOI: 10.3390/vaccines10060961] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
209 Israel A, Schäffer AA, Merzon E, Green I, Magen E, Golan-Cohen A, Vinker S, Ruppin E. A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received. Microorganisms 2022;10:1238. [PMID: 35744754 DOI: 10.3390/microorganisms10061238] [Reference Citation Analysis]
210 Volckmar J, Melcher L, Bruder D. Route, origin & valence matter: towards sophisticated next-generation vaccines to cope with the COVID-19 pandemic. Signal Transduct Target Ther 2022;7:188. [PMID: 35705533 DOI: 10.1038/s41392-022-01053-4] [Reference Citation Analysis]
211 K A, Sharma A, Kumar D, Singh SK, Gupta G, Chellappan DK, Dua K, Nagraik R. Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review. J Med Virol 2022. [PMID: 35705439 DOI: 10.1002/jmv.27936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
212 Bert F, Scaioli G, Vola L, Accortanzo D, Lo Moro G, Siliquini R. Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries. Int J Environ Res Public Health 2022;19:7233. [PMID: 35742479 DOI: 10.3390/ijerph19127233] [Reference Citation Analysis]
213 Meng Z, Ma D, Duan S, Zhang J, Yue R, Li X, Gao Y, Li X, Zeng F, Xu X, Jiang G, Liao Y, Fan S, Niu Z, Li D, Yu L, Zhao H, Xu X, Wang L, Zhang Y, Liu L, Li Q. Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine. Vaccines (Basel) 2022;10. [PMID: 35746536 DOI: 10.3390/vaccines10060929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
214 Kawasuji H, Morinaga Y, Tani H, Saga Y, Kaneda M, Murai Y, Ueno A, Miyajima Y, Fukui Y, Nagaoka K, Ono C, Matsuura Y, Niimi H, Yamamoto Y. Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population. J Infect Chemother 2022:S1341-321X(22)00158-1. [PMID: 35691864 DOI: 10.1016/j.jiac.2022.05.009] [Reference Citation Analysis]
215 Hager KJ, Pérez Marc G, Gobeil P, Diaz RS, Heizer G, Llapur C, Makarkov AI, Vasconcellos E, Pillet S, Riera F, Saxena P, Geller Wolff P, Bhutada K, Wallace G, Aazami H, Jones CE, Polack FP, Ferrara L, Atkins J, Boulay I, Dhaliwall J, Charland N, Couture MMJ, Jiang-Wright J, Landry N, Lapointe S, Lorin A, Mahmood A, Moulton LH, Pahmer E, Parent J, Séguin A, Tran L, Breuer T, Ceregido MA, Koutsoukos M, Roman F, Namba J, D'Aoust MA, Trepanier S, Kimura Y, Ward BJ; CoVLP Study Team. Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine. N Engl J Med 2022;386:2084-96. [PMID: 35507508 DOI: 10.1056/NEJMoa2201300] [Cited by in Crossref: 55] [Cited by in F6Publishing: 25] [Article Influence: 55.0] [Reference Citation Analysis]
216 Bignon E, Marazzi M, Monari A. Hijacking of Cellular Functions by Severe Acute Respiratory Syndrome Coronavirus-2. Permeabilization and Polarization of the Host Lipid Membrane by Viroporins. J Phys Chem Lett 2022;13:4642-9. [PMID: 35593652 DOI: 10.1021/acs.jpclett.2c01102] [Reference Citation Analysis]
217 Jeewandara C, Aberathna IS, Pushpakumara PD, Kamaladasa A, Guruge D, Wijesinghe A, Gunasekera B, Ramu ST, Kuruppu H, Ranasinghe T, Dayarathna S, Dissanayake O, Gamalath N, Ekanayake D, Jayamali J, Jayathilaka D, Dissanayake M, Jayadas TT, Mudunkotuwa A, Somathilake G, Harvie M, Nimasha T, Danasekara S, Wijayamuni R, Schimanski L, Rijal P, Tan TK, Dong T, Townsend A, Ogg GS, Malavige GN. Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine. Immun Inflamm Dis 2022;10:e621. [PMID: 35634958 DOI: 10.1002/iid3.621] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
218 Islam F, Dhawan M, Nafady MH, Emran TB, Mitra S, Choudhary OP, Akter A. Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions. Annals of Medicine and Surgery 2022;78:103737. [DOI: 10.1016/j.amsu.2022.103737] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
219 Bignon E, Marazzi M, Grandemange S, Monari A. Autophagy and evasion of the immune system by SARS-CoV-2. Structural features of the non-structural protein 6 from wild type and Omicron viral strains interacting with a model lipid bilayer. Chem Sci 2022;13:6098-105. [PMID: 35685814 DOI: 10.1039/d2sc00108j] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
220 Stosic M, Milic M, Markovic M, Kelic I, Bukumiric Z, Veljkovic M, Kisic Tepavcevic D, Saponjic V, Plavsa D, Jovanovic S, Jovanovic V. Immunogenicity and Reactogenicity of the Booster Dose of COVID-19 Vaccines and Related Factors: A Panel Study from the General Population in Serbia. Vaccines (Basel) 2022;10. [PMID: 35746446 DOI: 10.3390/vaccines10060838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
221 Lupașcu (Moisi) RE, Ilie MI, Velescu BȘ, Udeanu DI, Sultana C, Ruță S, Arsene AL. COVID-19-Current Therapeutical Approaches and Future Perspectives. Processes 2022;10:1053. [DOI: 10.3390/pr10061053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Liwsrisakun C, Pata S, Laopajon W, Takheaw N, Chaiwong W, Inchai J, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Chuensirikulchai K, Kasinrerk W. Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine. Immun Ageing 2022;19:24. [PMID: 35610643 DOI: 10.1186/s12979-022-00279-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Brazete C, Pinto M, Sá L, Aguiar A, Alves F, Duarte R. Evaluation of the Real-World Effectiveness of Vaccines against COVID-19 at a Local Level: Protocol for a Test-Negative Case-Control Study. Vaccines (Basel) 2022;10:822. [PMID: 35632578 DOI: 10.3390/vaccines10050822] [Reference Citation Analysis]
224 Falodun O, Medugu N, Sabir L, Jibril I, Oyakhire N, Adekeye A. An epidemiological study on face masks and acne in a Nigerian population. PLoS ONE 2022;17:e0268224. [DOI: 10.1371/journal.pone.0268224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Bachelet VC, Silva-Ayarza I, Lizana FJ, Gomolán P, Silva-Villalobos D, Navarrete MS. SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: the COmmunity Cohort Study protocol. BMJ Open 2022;12:e061345. [PMID: 35589344 DOI: 10.1136/bmjopen-2022-061345] [Reference Citation Analysis]
226 Wang X, Rcheulishvili N, Cai J, Liu C, Xie F, Hu X, Yang N, Hou M, Papukashvili D, He Y, Wang PG. Development of DNA Vaccine Candidate against SARS-CoV-2. Viruses 2022;14:1049. [DOI: 10.3390/v14051049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
227 Arino H, Muramae N, Okano M, Mori K, Otsui K, Sakaguchi K. Acute Onset of Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Two Weeks After COVID-19 Vaccination With mRNA-1273 With Possible Activation of Parvovirus B19: A Case Report With Literature Review. Cureus 2022. [DOI: 10.7759/cureus.24952] [Reference Citation Analysis]
228 Sarno G, Calabrese P, Schiavo L, Izzo F, Pilone V. What are risk factors for COVID-19 vaccine breakthrough infections in patients with previous history of bariatric surgery? EXCLI J 2022;21:786-90. [PMID: 35949488 DOI: 10.17179/excli2022-4873] [Reference Citation Analysis]
229 Ticinesi A, Nouvenne A, Parise A, Prati B, Meschi T. Defining SARS-CoV-2 breakthrough infection needing hospitalization in mass vaccination era: from disease-centered to patient-centered care. Acta Biomed 2022;93:e2022182. [PMID: 35546003 DOI: 10.23750/abm.v93i2.12717] [Reference Citation Analysis]
230 Li Y, Rao M, Xu G. New-Onset Acute Kidney Disease Post COVID-19 Vaccination. Vaccines 2022;10:742. [DOI: 10.3390/vaccines10050742] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
231 Dhawan M, Sharma A, Priyanka, Thakur N, Rajkhowa TK, Choudhary OP. Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions. Hum Vaccin Immunother 2022;:2068883. [PMID: 35507895 DOI: 10.1080/21645515.2022.2068883] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
232 Matsumoto N, Higuchi C, Mitsuhashi T, Hagiya H, Takao S, Yorifuji T. Adverse reactions and attitudes toward vaccines among young populations one month after receiving a second dose of mRNA-1273 in Japan. GHM 2022;4:141-143. [DOI: 10.35772/ghm.2021.01125] [Reference Citation Analysis]
233 Zabalza A, Arrambide G, Otero-Romero S, Pappolla A, Tagliani P, López-Maza S, Cárdenas-Robledo S, Esperalba J, Fernández-Naval C, Martínez-Gallo M, Castillo M, Bonastre M, Resina-Salles M, Bertran J, Rodriguez-Barranco M, Carbonell-Mirabent P, Gonzalez M, Merchan M, Quiroga-Varela A, Miguela A, Gómez I, Álvarez G, Robles R, Perez Del Campo D, Queralt X, Soler MJ, Agraz I, Martinez-Valle F, Rodríguez-Acevedo B, Midaglia L, Vidal-Jordana Á, Cobo-Calvo Á, Tur C, Galan I, Castillo J, Río J, Espejo C, Comabella M, Nos C, Sastre-Garriga J, Ramió-Torrentà L, Tintoré M, Montalban X. Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases? Mult Scler 2022;:13524585221089540. [PMID: 35475363 DOI: 10.1177/13524585221089540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
234 Zhang M, Gong Y, Jiao S. Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent. Future Virology. [DOI: 10.2217/fvl-2021-0100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Ballesteros-sanabria L, Pelaez-prestel HF, Ras-carmona A, Reche PA. Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants. Biomedicines 2022;10:996. [DOI: 10.3390/biomedicines10050996] [Reference Citation Analysis]
236 Vokó Z, Kiss Z, Surján G, Surján O, Barcza Z, Wittmann I, Molnár GA, Nagy D, Müller V, Bogos K, Nagy P, Kenessey I, Wéber A, Polivka L, Pálosi M, Szlávik J, Rokszin G, Müller C, Szekanecz Z, Kásler M. Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 study).. [DOI: 10.1101/2022.04.14.22273898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 Richardson VL, Camacho Franco MA, Márquez AB, Valdez LM, Castro Ceronio LE, Cruz VC, Gharpure R, Lafond KE, Yau TS, Azziz-baumgartner E, Hernández Ávila M. Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers – Mexico, March–December 2021.. [DOI: 10.1101/2022.04.14.22273413] [Reference Citation Analysis]
238 Pereson MJ, Amaya L, Neukam K, Bare P, Echegoyen N, Badano MN, Lucero A, Martelli A, Garcia GH, Videla C, Martínez AP, Di Lello FA. Heterologous Gam-COVID-Vac (Sputnik V) / mRNA-1273 (Moderna) vaccination induces a stronger humoral response than homologous Sputnik V in a real-world data analysis.. [DOI: 10.1101/2022.04.08.22273532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
239 Pavan M, Bassani D, Sturlese M, Moro S. Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)? J Enzyme Inhib Med Chem 2022;37:1077-82. [PMID: 35418253 DOI: 10.1080/14756366.2022.2062336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Bignon E, Marazzi M, Monari A. Hijacking of Cellular Functions by Severe Acute Respiratory Syndrome Coronavirus-2. Permeabilization and Polarization of the Host Lipid Membrane by Viroporins.. [DOI: 10.1101/2022.04.14.488372] [Reference Citation Analysis]
241 Soraci L, Lattanzio F, Soraci G, Gambuzza ME, Pulvirenti C, Cozza A, Corsonello A, Luciani F, Rezza G. COVID-19 Vaccines: Current and Future Perspectives. Vaccines 2022;10:608. [DOI: 10.3390/vaccines10040608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
242 Premikha M, Chiew CJ, Wei WE, Leo YS, Ong B, Lye DC, Lee VJ, Tan KB. Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore. Clin Infect Dis 2022:ciac288. [PMID: 35412612 DOI: 10.1093/cid/ciac288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
243 Li Q, Zhang M, Liang Z, Zhang L, Wu X, Yang C, An Y, Tong J, Liu S, Li T, Cui Q, Nie J, Wu J, Huang W, Wang Y. Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD. MedComm 2022;3. [DOI: 10.1002/mco2.130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
244 Cavani M, Riofrío WA, Arciniega M. Molecular Dynamics and MM-PBSA Analysis of the SARS-CoV-2 Gamma Variant in Complex with the hACE-2 Receptor. Molecules 2022;27:2370. [PMID: 35408761 DOI: 10.3390/molecules27072370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
245 Chavda VP, Bezbaruah R, Athalye M, Parikh PK, Chhipa AS, Patel S, Apostolopoulos V. Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena. Viruses 2022;14:759. [DOI: 10.3390/v14040759] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
246 Madewell ZJ, Yang Y, Longini IM Jr, Halloran ME, Dean NE. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis. JAMA Netw Open 2022;5:e229317. [PMID: 35482308 DOI: 10.1001/jamanetworkopen.2022.9317] [Cited by in Crossref: 57] [Cited by in F6Publishing: 25] [Article Influence: 57.0] [Reference Citation Analysis]
247 Cazzato G, Romita P, Foti C, Lobreglio D, Trilli I, Colagrande A, Ingravallo G, Resta L. Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation? Vaccines 2022;10:532. [DOI: 10.3390/vaccines10040532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
248 Yang J, Liao Y, Hua Q, Lv H. A Survey of Awareness of COVID-19 Knowledge, Willingness and Influencing Factors of COVID-19 Vaccination. Vaccines 2022;10:524. [DOI: 10.3390/vaccines10040524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
249 Belete TM. The Immune Response, Safety, and Efficacy of Emergency Use Authorization-Granted COVID-19 Vaccines: A Review. TOMICROJ 2022;16:e187428582201240. [DOI: 10.2174/18742858-v16-e2201240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Ullah M, Mubashir M, Atique H, Aslam F, Tahir M, Naqvi M. COVID-19 Infection in Vaccinated Healthcare Professionals. Cureus. [DOI: 10.7759/cureus.23386] [Reference Citation Analysis]
251 Álvarez-díaz DA, Muñoz AL, Herrera-sepúlveda MT, Tavera-rodríguez P, Laiton-donato K, Franco-muñoz C, Ruiz-moreno HA, Pelaez-carvajal D, Muñoz-suarez AM, Galindo M, Reales-gonzalez J, Catama JD, De Arco BH, Cobos T, Arias-ramirez EJ, Mercado-reyes M. Neutralizing responses in fully vaccinated with BNT162b2, CoronaVac, ChAdOx1, and Ad26.COV2.S against SARS-CoV-2 lineages in Colombia, 2020-2021.. [DOI: 10.1101/2022.03.15.22272371] [Reference Citation Analysis]
252 Alimohammadi R, Porgoo M, Eftekhary M, Kiaie SH, Dezfouli EA, Dehghani M, Nasrollahi K, Malekshahabi T, Heidari M, Pouya S, Alimohammadi M, Khavas DS, Modaresi MS, Ghasemi MH, Ramyar H, Mohammadipour F, Hamzelouei F, Mofayezi A, Mottaghi SS, Rahmati A, Razzaznian M, Tirandazi V, Borzouee F, Sadeghi H, Mohammadi MH, Rastegar L, Safar Sajadi SM, Ehsanbakhsh H, Bazmbar H, Nouraee MS, Pazooki P, Pahlevanneshan M, Alishah K, Nasiri F, Mokhberian N, Mohammadi SS, Akar S, Niknam H, Azizi M, Ajoudanian M, Moteallehi-ardakani MH, Mousavi Shaegh SA, Ramezani R, Salimi V, Moazzami R, Hashemi SM, Dehghanizadeh S, Khoddami V. mRNA-based vaccine candidate COReNAPCIN® induces robust humoral and cellular immunity in mice and non-human primates.. [DOI: 10.1101/2022.03.05.483092] [Reference Citation Analysis]
253 Cañas CA, Posso-osorio I, Bedoya-joaqui V, López HE, Tobón GJ. An idiotypic network dysregulation could be related to the pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT) following vaccination with vaccines expressing Spike protein of SARS CoV2. Intern Emerg Med. [DOI: 10.1007/s11739-022-02956-4] [Reference Citation Analysis]
254 Oroszi B, Juhász A, Nagy C, Horváth JK, Komlós KE, Túri G, Mckee M, Ádány R. Characteristics of the Third COVID-19 Pandemic Wave with Special Focus on Socioeconomic Inequalities in Morbidity, Mortality and the Uptake of COVID-19 Vaccination in Hungary. JPM 2022;12:388. [DOI: 10.3390/jpm12030388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
255 Xiong X, Wong CKH, Au ICH, Lai FTT, Li X, Wan EYF, Chui CSL, Chan EWY, Cheng FWT, Lau KTK, Lee CH, Woo YC, Lui DTW, Wong ICK. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study. Thyroid 2022;32:505-14. [PMID: 35216517 DOI: 10.1089/thy.2021.0684] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
256 Kawasuji H, Morinaga Y, Tani H, Saga Y, Kaneda M, Murai Y, Ueno A, Miyajima Y, Fukui Y, Nagaoka K, Ono C, Matsuura Y, Niimi H, Yamamoto Y. Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population.. [DOI: 10.1101/2022.02.23.22271433] [Reference Citation Analysis]
257 Ghazy RM, Ashmawy R, Hamdy NA, Elhadi YAM, Reyad OA, Elmalawany D, Almaghraby A, Shaaban R, Taha SHN. Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. Vaccines 2022;10:350. [DOI: 10.3390/vaccines10030350] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
258 Jutel M, Torres MJ, Palomares O, Akdis CA, Eiwegger T, Untersmayr E, Barber D, Zemelka-Wiacek M, Kosowska A, Palmer E, Vieths S, Mahler V, Canonica WG, Nadeau K, Shamji MH, Agache I. COVID-19  vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations. Allergy 2022. [PMID: 35147230 DOI: 10.1111/all.15252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
259 Porru S, Spiteri G, Monaco MGL, Valotti A, Carta A, Lotti V, Diani E, Lippi G, Gibellini D, Verlato G. Post-Vaccination SARS-CoV-2 Infections among Health Workers at the University Hospital of Verona, Italy: A Retrospective Cohort Survey. Vaccines 2022;10:272. [DOI: 10.3390/vaccines10020272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
260 Zhao F, Ma Q, Yue Q, Chen H. SARS-CoV-2 Infection and Lung Regeneration. Clin Microbiol Rev 2022;:e0018821. [PMID: 35107300 DOI: 10.1128/cmr.00188-21] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
261 Terpos E, Karalis V, Ntanasis-stathopoulos I, Evangelakou Z, Gavriatopoulou M, Manola MS, Malandrakis P, Gianniou DD, Kastritis E, Trougakos IP, Dimopoulos MA. Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222. Biomedicines 2022;10:338. [DOI: 10.3390/biomedicines10020338] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
262 Giannini S, Giusti A, Minisola S, Napoli N, Passeri G, Rossini M, Sinigaglia L. The Immunologic Profile of Vitamin D and Its Role in Different Immune-Mediated Diseases: An Expert Opinion. Nutrients 2022;14:473. [PMID: 35276834 DOI: 10.3390/nu14030473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
263 Madewell ZJ, Yang Y, Longini IM Jr, Halloran ME, Dean NE. Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis. medRxiv 2022:2022. [PMID: 35043125 DOI: 10.1101/2022.01.09.22268984] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
264 Bignon E, Marazzi M, Grandemange S, Monari A. Autophagy and evasion of immune system by SARS-CoV-2. Structural features of the Non-structural protein 6 from Wild Type and Omicron viral strains interacting with a model lipid bilayer. .. [DOI: 10.1101/2022.01.05.475107] [Reference Citation Analysis]
265 Öztürk BÖ, Akdemir İ, Azap A, Çelik G, Bavbek S, Mungan D. Anaphylaxis is rare due to CoronaVac in a population of healthcare workers. Asia Pac Allergy 2022;12. [DOI: 10.5415/apallergy.2022.12.e35] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Bocchino M, Rea G, Buonocore A, Lieto R, Mazzocca A, Di Domenico A, Stanziola AA. Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination. Respiratory Medicine Case Reports 2022;38:101674. [DOI: 10.1016/j.rmcr.2022.101674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Al-domaidat D, Algarni M, Alshaikh Hasan R, Amoodi H. Laryngotracheal Stenosis Following Intubation for COVID-19 Pneumonia: A Report of Two Cases. IJOHNS 2022;11:234-241. [DOI: 10.4236/ijohns.2022.115025] [Reference Citation Analysis]
268 Tang X, Pei Y, Wang X, Jiang L, Liu P, Chen Y, Meng Z. Mental health and fatigue status of the medical workforce during the COVID-19 outbreak in the Yangzhou city, China. Front Psychiatry 2022;13:1018069. [PMID: 36325526 DOI: 10.3389/fpsyt.2022.1018069] [Reference Citation Analysis]
269 Becskei A, Rahaman S. The life and death of RNA across temperatures. Computational and Structural Biotechnology Journal 2022;20:4325-36. [DOI: 10.1016/j.csbj.2022.08.008] [Reference Citation Analysis]
270 Valdés-stauber J. Wie hat das Coronavirus unsere sichere Welt der Selbstverständlichkeiten verändert? Brücken zwischen Psychiatrie und Philosophie 2022. [DOI: 10.1007/978-3-662-64295-5_14] [Reference Citation Analysis]
271 Sokhansanj BA, Zhao Z, Rosen GL. Interpretable and Predictive Deep Modeling of the SARS-CoV-2 Spike Protein Sequence.. [DOI: 10.1101/2021.12.26.21268414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
272 Dambadarjaa D, Altankhuyag GE, Chandaga U, Khuyag SO, Batkhorol B, Khaidav N, Dulamsuren O, Gombodorj N, Dorjsuren A, Singh P, Nyam G, Otganbayar D, Tserennadmid N. Factors Associated with COVID-19 Vaccine Hesitancy in Mongolia: A Web-Based Cross-Sectional Survey. Int J Environ Res Public Health 2021;18:12903. [PMID: 34948511 DOI: 10.3390/ijerph182412903] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
273 Weinberger B. Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population. Vaccines (Basel) 2021;9:1435. [PMID: 34960181 DOI: 10.3390/vaccines9121435] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
274 Sariol CA, Serrano-Collazo C, Ortiz EJ, Pantoja P, Cruz L, Arana T, Atehortua D, Pabon-Carrero C, Espino AM. Limited Impact of Delta Variant's Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population. Viruses 2021;13:2405. [PMID: 34960674 DOI: 10.3390/v13122405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
275 Higdon MM, Wahl B, Jones CB, Rosen JG, Truelove SA, Baidya A, Nande AA, Shamaeizadeh PA, Walter KK, Feikin DR, Patel MK, Knoll MD, Hill AL. A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease.. [DOI: 10.1101/2021.09.17.21263549] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]